Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region
(352) 733-0111

Clinical trials

  • RPC01-3203

    This is a study to demonstrate the effect of oral ozanimod as maintenance therapy in participants with moderately to severely active Crohn's Disease.

    Investigator
    Angela Pham
    Ages
    18 Years - 75 Years
    Sexes
    All
  • RPC01-3201

    This is a study to explore the effect of oral ozanimod as an induction treatment for participants with moderately to severely active Crohn's Disease.

    Investigator
    Angela Pham
    Ages
    18 Years - 75 Years
    Sexes
    All
  • RPC01-3204

    This is an extension study to evaluate safety and efficacy of ozanimod in participants with moderately to severely active Crohn's Disease.

    Investigator
    Angela Pham
    Ages
    18 Years - 75 Years
    Sexes
    All